EBSEmergent BioSolutions Inc.vs its industry peers
A metric-by-metric comparison of Emergent BioSolutions Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBSEsta | $310M#2 | — | 1.0x#3 | 0.4x#1 | -28.8%#3 | 127.6%#1 | 13.5%#1 | 16.8%#1 | 9.9%#1 | 7#1 | -42.6%#2 | — |
| BLSM | $400M#1 | — | — | — | — | — | — | — | — | — | — | — |
| VOGX | $307M#3 | — | — | — | — | — | — | — | — | — | — | — |
| PRLD | $307M#4 | — | 2.3x#6 | 25.3x#3 | 73.4%#1 | 21.8%#2 | -861.3%#3 | -74.4%#5 | — | — | — | — |
| SPRY | $299M#5 | — | 23.9x#7 | 3.5x#2 | -5.5%#2 | -2241.8%#8 | -212.9%#2 | -1369.1%#8 | -177.6%#2 | — | — | — |
| BNTC | $296M#6 | — | 1.7x#5 | — | -100.0%#5 | -20.6%#4 | — | -25.8%#3 | — | — | — | — |
| MPLT | $292M#7 | 0.1x#1 | 0.8x#1 | — | — | -107.7%#6 | — | -46.3%#4 | — | — | — | — |
| TTRX | $291M#8 | — | 423.9x#8 | — | — | -80.6%#5 | — | -465.0%#7 | — | — | — | — |
| FULC | $286M#9 | — | 0.9x#2 | — | -100.0%#5 | -670.0%#7 | — | -24.1%#2 | — | — | — | — |
| LYEL | $279M#10 | — | 1.2x#4 | 7742.9x#4 | -41.0%#4 | 20.0%#3 | -748344.4%#4 | -117.4%#6 | — | — | -30.6%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice